Emergent BioSolutions
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-4.33-4.29-9.03
Price/Sales ratio
0.430.420.54
Earnings per Share (EPS)
$-2.10$-2.12$-1.01

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
27.6724.5625.4823.5247.3650.9815.4410.59-2.64-0.16-2.9450.98
Price/Sales ratio
2.252.952.693.463.792.513.031.290.520.110.582.51
Price/Book Value ratio
1.832.332.212.122.932.553.261.430.420.180.472.55
Price/Cash Flow ratio
9.0534.7324.679.3371.0514.778.807.24-17.35-0.59-19.3314.77
Price/Free Cash Flow ratio
12.45-4.37K-57.9512.67-98.0127.4811.9524.20-3.94-0.47-3.83-98.01
Price/Earnings Growth ratio
1.980.37-1.220.43-1.28-3.350.03-0.360.01-0.000.01-1.28
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
73.69%76.22%73.14%65.10%58.80%60.80%66.31%57.74%38.11%32.77%38.11%60.80%
Operating Profit Margin
12.89%18.37%21.58%22.15%11.47%10.31%27.88%19.66%-14.80%-69.22%-14.80%10.31%
Pretax Profit Margin
11.78%17.17%20.29%21.15%10.41%6.99%26.17%17.53%-19.77%-69.68%-19.77%6.99%
Net Profit Margin
8.16%12.02%10.59%14.72%8.01%4.92%19.66%12.24%-19.96%-72.47%-19.96%4.92%
Effective Tax Rate
30.75%29.96%36.98%30.37%23.06%29.58%25.07%26.55%-0.94%-4.00%-0.94%29.58%
Return on Assets
3.88%6.02%5.33%7.71%2.81%2.33%10.60%7.41%-7.06%-41.71%-7.06%2.33%
Return On Equity
6.64%9.52%8.68%9.05%6.20%5.00%21.13%13.55%-16.18%-117.12%-15.11%5.00%
Return on Capital Employed
6.81%10.17%12.20%12.81%4.42%5.39%17.36%13.63%-8.57%-61.98%-8.57%5.39%
Liquidity Ratios
Current Ratio
4.655.404.814.853.093.173.11N/AN/AN/A0.983.17
Quick Ratio
3.944.634.123.422.072.142.312.460.690.530.652.14
Cash ratio
3.013.142.561.780.550.771.611.540.520.170.520.77
Days of Sales Outstanding
48.8084.11110.8795.07122.4589.3354.1856.7851.8466.4351.5789.33
Days of Inventory outstanding
202.43225.92205.74266.34233.06187.34213.84169.03185.10170.18185.10187.34
Operating Cycle
251.24310.04316.61361.42355.52276.67268.02225.81236.94236.62197.82276.67
Days of Payables Outstanding
126.16111.5096.3377.9591.3979.8294.8062.1154.4558.0554.4579.82
Cash Conversion Cycle
125.07198.54220.28283.46264.13196.85173.22163.70182.48178.5642.76196.85
Debt Ratios
Debt Ratio
0.260.230.270.010.350.340.300.280.440.470.560.35
Debt Equity Ratio
0.450.370.440.010.780.740.600.511.011.321.280.78
Long-term Debt to Capitalization
0.310.270.290.010.430.420.360.330.240.400.240.42
Total Debt to Capitalization
0.310.270.310.010.440.420.370.340.500.560.500.44
Interest Coverage Ratio
7.0414.7213.8518.859.072.9713.85N/AN/AN/A-4.452.97
Cash Flow to Debt Ratio
0.440.180.1915.410.050.230.610.38-0.02-0.23-0.020.23
Company Equity Multiplier
1.701.581.621.172.202.131.991.822.282.802.282.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.240.080.100.370.050.160.340.17-0.03-0.19-0.030.16
Free Cash Flow / Operating Cash Flow Ratio
0.72-0.00-0.420.73-0.720.530.730.294.391.255.03-0.72
Cash Flow Coverage Ratio
0.440.180.1915.410.050.230.610.38-0.02-0.23-0.020.23
Short Term Coverage Ratio
N/AN/A2.67N/A4.1314.5715.8510.16-0.03-0.49-0.0314.57
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A